Ado-trastuzumab emtansine Intravenous and Incruse Ellipta
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Indacaterol
- Ado-trastuzumab emtansine Intravenous-Indacaterol and Glycopyrrolate
- Ado-trastuzumab emtansine Intravenous-Indacaterol and glycopyrrolate Inhalation
- Ado-trastuzumab emtansine Intravenous-Indacaterol inhalation
- Ado-trastuzumab emtansine Intravenous-Indacaterol Maleate
- Ado-trastuzumab emtansine Intravenous-Indapamide
- Incruse Ellipta-Adox Pak 2/100
- Incruse Ellipta-Adoxa
- Incruse Ellipta-Adoxa CK
- Incruse Ellipta-Adoxa Pak
- Incruse Ellipta-Adoxa Pak 1/100
- Incruse Ellipta-Adoxa Pak 1/150